496 related articles for article (PubMed ID: 32502585)
21. Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic.
Sohier P; Matar S; Meritet JF; Laurent-Roussel S; Dupin N; Aractingi S
Arch Pathol Lab Med; 2021 Feb; 145(2):137-144. PubMed ID: 33501498
[TBL] [Abstract][Full Text] [Related]
22. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France.
de Masson A; Bouaziz JD; Sulimovic L; Cassius C; Jachiet M; Ionescu MA; Rybojad M; Bagot M; Duong TA;
J Am Acad Dermatol; 2020 Aug; 83(2):667-670. PubMed ID: 32380219
[No Abstract] [Full Text] [Related]
23. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
[TBL] [Abstract][Full Text] [Related]
24. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
Massey PR; Jones KM
Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
[TBL] [Abstract][Full Text] [Related]
25. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.
Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Takeshita J; French LE; Thiers BH; Hruza GJ; Fox LP;
J Am Acad Dermatol; 2020 Aug; 83(2):486-492. PubMed ID: 32479979
[TBL] [Abstract][Full Text] [Related]
26. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
[TBL] [Abstract][Full Text] [Related]
27. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
[TBL] [Abstract][Full Text] [Related]
28. Chilblain-like lesions with prominent bullae in a patient with COVID-19.
Rubin A; Alamgir M; Rubin J; Rao BK
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.
Gómez-Fernández C; López-Sundh AE; González-Vela C; Ocejo-Vinyals JG; Mayor-Ibarguren A; Salas-Venero CA; Gutiérrez-Larrañaga M; Tejerina-Puente A; Fariñas MC; Cabero-Pérez MJ; López-Hoyos M; González-López MA
Int J Dermatol; 2020 Dec; 59(12):1475-1484. PubMed ID: 33070314
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.
Herman A; Peeters C; Verroken A; Tromme I; Tennstedt D; Marot L; Dachelet C; Gruson D; Hermans C; Baeck M
JAMA Dermatol; 2020 Sep; 156(9):998-1003. PubMed ID: 32584377
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
[No Abstract] [Full Text] [Related]
32. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.
Piccolo V; Neri I; Filippeschi C; Oranges T; Argenziano G; Battarra VC; Berti S; Manunza F; Fortina AB; Di Lernia V; Boccaletti V; De Bernardis G; Brunetti B; Mazzatenta C; Bassi A
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e291-e293. PubMed ID: 32330334
[No Abstract] [Full Text] [Related]
33. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.
Denina M; Pellegrino F; Morotti F; Coppo P; Bonsignori IM; Garazzino S; Ravanini P; Avolio M; Cavallo R; Bertolotti L; Felici E; Acucella G; Montin D; Rabbone I; Licciardi F
J Am Acad Dermatol; 2020 Dec; 83(6):1751-1753. PubMed ID: 32781180
[No Abstract] [Full Text] [Related]
34. Case Report: Chilblains-like lesions (COVID-19 toes) during the pandemic - is there a diagnostic window?
Ludzik J; Witkowski A; Hansel DE; Raess PW; White K; Leachman S
F1000Res; 2020; 9():668. PubMed ID: 32913640
[TBL] [Abstract][Full Text] [Related]
35. Clustered cases of acral perniosis: Clinical features, histopathology, and relationship to COVID-19.
Cordoro KM; Reynolds SD; Wattier R; McCalmont TH
Pediatr Dermatol; 2020 May; 37(3):419-423. PubMed ID: 32396999
[TBL] [Abstract][Full Text] [Related]
36. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
Kashetsky N; Mukovozov IM; Bergman J
J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.
Jindal R; Chauhan P; Goyal D; Shirazi N
Dermatol Ther; 2021 May; 34(3):e14951. PubMed ID: 33740317
[TBL] [Abstract][Full Text] [Related]
38. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2.
Fertitta L; Welfringer-Morin A; Ouedrani A; Polivka L; Chhun S; Chatenoud L; Fourgeaud J; Hadj-Rabia S; Temmam S; Eloit M; Sermet-Gaudelus I; Bodemer C
J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e164-e167. PubMed ID: 33010072
[No Abstract] [Full Text] [Related]
39. SARS-CoV-2-related chilblains.
Ladha MA; Dupuis EC
CMAJ; 2020 Jul; 192(28):E804. PubMed ID: 32660940
[No Abstract] [Full Text] [Related]
40. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
Marzano AV; Cassano N; Genovese G; Moltrasio C; Vena GA
Br J Dermatol; 2020 Sep; 183(3):431-442. PubMed ID: 32479680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
